Water treatment innovator Fluence (ASX:FLC) has delivered a standout performance for the fiscal year ended Dec. 31, 2025, reporting a 52% surge in annual revenue to $78.4 million.
The company met its full-year guidance, swinging from an $8 million EBITDA loss in 2024 to a $4 million EBITDA profit in 2025.
The turnaround was driven by a combination of high-margin product sales and significant progress on the Ivory Coast water treatment project, which contributed $27.5 million in revenue.
The company's strategic shift toward Smart Product Solutions and recurring revenue reached a new milestone in Q4, marking the largest order quarter for these segments in the company's history.
Total new orders for the year rose to $64.2 million, leaving Fluence with a robust backlog of $74.8 million heading into 2026.